Tag: Cannara Biotech Inc.

February 20, 2020

Cannara Insiders Form Buying Group to Fully Acquire FSD/FV Pharma’s Position in Cannara

Insiders' increase stake in Cannara coincides as cultivation poised to commence
February 20, 2020

FSD Pharma Generates $7.7 Million in Proceeds and 670 Percent Return on Investment through Sale of Interest in Cannara Biotech

FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA:0K9A) today announced the sale of its 12% equity interest in Cannara Biotech Inc.
February 3, 2020

Cannara Biotech’s Farnham Facility Receives Cultivation Licence

Cannara Biotech Inc. announced the receipt of its cultivation licence from Health Canada for Phase 1 of its purpose-built Farnham...
January 20, 2020

Cannara Biotech Reports Q1 2020 Financial Results

Cannara Biotech Inc. (CSE:LOVE, OTCQB:LOVFF, FRA:8CB) announced financial results for the three-month period ended November 30, 2019.
November 27, 2019

Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

Cannara Biotech Inc. (CSE:LOVE, FRA:8CB, OTCQB:LOVFF) announced financial results for the three month period and year ended August 31, 2019.
October 10, 2019

Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

Cannara Biotech announced it has secured a mortgage against its Farnham Facility in the value of $6 million with the Canadian Imperial...
September 12, 2019

Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility

Cannara Biotech Inc. announced it has submitted to Health Canada its site evidence package for Phase One of the cultivation...